Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1984;70:806-811

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franzeck, U. K.
Right arrow Articles by Huch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franzeck, U. K.
Right arrow Articles by Huch, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN

Circulation, Vol 70, 806-811, Copyright © 1984 by American Heart Association


ARTICLES

Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence

UK Franzeck, A Bollinger, R Huch and A Huch

The transparent oxygen electrode, recently developed by Huch and his co- workers, permits monitoring of transcutaneous oxygen tension (tcPO2) at defined sites on the capillaroscopic image obtained by videomicroscopy. This combined system has been applied to study the nutritional skin capillaries of patients with chronic venous incompetence (CVI). The results of 44 studies in 17 patients with CVI demonstrated a direct correlation between tcPO2 and density and morphologic characteristics of the superficial capillaries. The mean tcPO2 was 47.7 +/- 14.4 mm Hg at the site of incompetent perforating veins of the ankle without major trophic changes. There was no statistically significant difference between the mean values obtained in patients and control subjects (56.8 +/- 9.9 mm Hg). Videomicroscopic examination revealed dilated and tortuous capillaries surrounded by halo formations. In areas of hyperpigmentation, induration, and hyperkeratosis, significantly decreased mean tcPO2 (22.5 +/- 7.0 mm Hg; p less than .001) corresponded to reduced capillary density (less than 10 capillaries/mm2). In avascular skin areas (scar tissue, white atrophy) tcPO2 was measured at 0 mm Hg. No capillaries, or a greatly reduced number, were visible at such sites, resulting in a distance between capillary and cathode tip of the oxygen sensor of greater than 100 micron. The combined system of tcPO2 measurement and simultaneous videomicroscopy gives new pathophysiologic information on the development of skin ulcers and may be useful for the objective comparison of different therapeutic modalities at the microcirculatory level.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
G. Belcaro, M. Rosaria Cesarone, A. Ledda, M. Cacchio, I. Ruffini, A. Ricci, E. Ippolito, A. Di Renzo, M. Dugall, M. Corsi, et al.
O-({beta}-Hydroxyethyl)-Rutosides Systemic and Local Treatment in Chronic Venous Disease and Microangiopathy: An Independent Prospective Comparative Study
Angiology, March 1, 2008; 59(1_suppl): 7S - 13S.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
G. Belcaro, M. R. Cesarone, A. Ledda, M. Cacchio, I. Ruffini, A. Ricci, E. Ippolito, A. Di Renzo, M. Dugall, M. Corsi, et al.
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-({beta}-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry
Angiology, March 1, 2008; 59(1_suppl): 14S - 20S.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. Rosaria Cesarone, G. Belcaro, S. Errichi, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
Microcirculatory Effects of Viatromb(R) Spray Gel Heparin in Chronic Venous Insufficiency: Evaluation of TcPO2 and PCO2--A Product Evaluation Study
Angiology, April 1, 2007; 58(1S): 21S - 26S.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
N. Labropoulos, P. J. Patel, J. E. Tiongson, L. Pryor, L. R. Leon Jr, and A. K. Tassiopoulos
Patterns of Venous Reflux and Obstruction in Patients With Skin Damage Due to Chronic Venous Disease
Vascular and Endovascular Surgery, February 1, 2007; 41(1): 33 - 40.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol(R): A Prospective, Controlled Study
Angiology, October 1, 2006; 57(5): 569 - 576.
[Abstract] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
U. Wollina, M. B. Abdel-Naser, and R. Mani
A review of the microcirculation in skin in patients with chronic venous insufficiency: the problem and the evidence available for therapeutic options.
International Journal of Lower Extremity Wounds, September 1, 2006; 5(3): 169 - 180.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
G. Belcaro, M. R. Cesarone, B. M. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, G. Gizzi, P. Rohdewald, et al.
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol.
Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 318 - 323.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
Comparison of Pycnogenol(R) and Daflon(R) in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study
Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 205 - 212.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, A. Di Renzo, I. Ruffini, G. Gizzi, E. Ippolito, et al.
Venoruton(R) vs Daflon(R): Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency
Angiology, March 1, 2006; 57(2): 131 - 138.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
G. Belcaro, M. R. Cesarone, B. M. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, P. Rohdewald, E. Ippolito, et al.
Venous Ulcers: Microcirculatory Improvement and Faster Healing with Local Use of Pycnogenol(R)
Angiology, November 1, 2005; 56(6): 699 - 705.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
G. Belcaro, M. R. Cesarone, G. Vinciguerra, A. Ledda, M. Dugall, A. Di Renzo, S. Stuard, A. Ricci, M. Cacchio, E. Ippolito, et al.
A Plaster Combining Diclofenac and Heparin: Microcirculatory Evaluation in 2 Models of High-Perfusion Microangiopathy
Angiology, November 1, 2005; 56(6): 707 - 713.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, et al.
HR, 0-(Beta-Hydroxyethyl)-Rutosides; (Venoruton(R)): Rapid Relief of Signs/Symptoms in Chronic Venous Insufficiency and Microangiopathy: A Prospective, Controlled Study
Angiology, March 1, 2005; 56(2): 165 - 172.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
M. R. Cesarone, G. Belcaro, L. Pellegrini, A. Ledda, A. Di Renzo, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, et al.
HR, 0-(Beta-Hydroxyethyl)-Rutosides, in Comparison with Diosmin+Hesperidin in Chronic Venous Insufficiency and Venous Microangiopathy: An Independent, Prospective, Comparative Registry Study
Angiology, January 1, 2005; 56(1): 1 - 8.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
K. Malanin, V. K. Havu, and P. J. Kolari
Dynamics of Cutaneous Laser Doppler Flux with Concentration of Moving Blood Cells and Blood Cell Velocity in Legs with Venous Ulcers and in Healthy Legs
Angiology, January 1, 2004; 55(1): 37 - 42.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. Belcaro, M. R. Cesarone, P. Bavera, A. Ricci, S. Renton, M. Leon, E. Ippolito, M. Dugall, and G. Acerbi
HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in Chronic Venous Disease and Microangiopathy: An Independent Prospective, Controlled, Randomized Trial
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 139 - 145.
[Abstract] [PDF]


Home page
CirculationHome page
M.-P. Jacob, M. Cazaubon, A. Scemama, D. Prie, F. Blanchet, M.-C. Guillin, and J.-B. Michel
Plasma Matrix Metalloproteinase-9 as a Marker of Blood Stasis in Varicose Veins
Circulation, July 30, 2002; 106(5): 535 - 538.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
L. Incandela, G. Belcaro, S. Renton, M. T. DeSanctis, M. R. Cesarone, P. Bavera, E. Ippolito, M. Bucci, M. Griffin, G. Geroulakos, et al.
HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1_suppl): S7 - S10.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
L. Incandela, M. R. Cesarone, M. T. DeSanctis, G. Belcaro, M. Dugall, and G. Acerbi
Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1_suppl): S11 - S15.
[Abstract] [PDF]


Home page
Vasc MedHome page
M. E Gschwandtner and H. Ehringer
Microcirculation in chronic venous insufficiency
Vascular Medicine, August 1, 2001; 6(3): 169 - 179.
[Abstract] [PDF]


Home page
CirculationHome page
A. N. Nicolaides
Investigation of Chronic Venous Insufficiency : A Consensus Statement
Circulation, November 14, 2000; 102 (20): e126 - e163.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
B. K. Ener
Dorsal Pedal Venous Oximetry for Assessing Treatment of Chronic Venous Insufficiency: Effects of Daflon 500 mg
Vascular and Endovascular Surgery, January 1, 2000; 34(1): 43 - 49.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
A. Bollinger, A.J. Leu, U. Hoffmann, and U.K. Franzeck
Microvascular Changes in Venous Disease: An Update
Angiology, January 1, 1997; 48(1): 27 - 32.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
J. A. Dormandy
Pathophysiology of Venous Leg Ulceration--An Update
Angiology, January 1, 1997; 48(1): 71 - 75.
[Abstract] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
W. W LaMORTE, P. R. Cordts, L. M. Hanrahan, T. E. Scott, C. Hartono, and J. O. Menzoian
Leukocytes, Lipids, and Chronic Venous Insufficiency: A New Perspective on an Old Disease
Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1993; 6(1): 95 - 107.
[PDF]


Home page
ANGIOLOGYHome page
W. R. Hiatt
Contemporary Treatment of Venous Lower Limb Ulcers
Angiology, October 1, 1992; 43(10): 852 - 855.
[Abstract] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
M. R. Nehler, G. L. Moneta, and J. M. Porter
The Lower Extremity Venous System Part II: The Pathophysiology of Chronic Venous Insufficiency
Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1992; 5(1): 81 - 97.
[PDF]


Home page
ANGIOLOGYHome page
G. V. Belcaro, R. Grimaldi, and G. Guidi
Improvement of Capillary Permeability in Patients with Venous Hypertension After Treatment with TTFCA
Angiology, July 1, 1990; 41(7): 533 - 540.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
H. Wollersheim and T. Thien
Hemodynamic Effects of Prostacyclin Infusions in Healthy Volunteers
Angiology, March 1, 1988; 39(3): 227 - 233.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
P. A. Modesti, M. Boddi, L. Poggesi, G. F. Gensini, and G. G. Neri Serneri
Transcutaneous Oximetry in Evaluation of the Initial Peripheral Artery Disease in Diabetics
Angiology, June 1, 1987; 38(6): 457 - 462.
[Abstract] [PDF]